Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
sight sciences
Overview
Sight Sciences is a rapidly growing, commercial-stage medical device company focused on developing and commercializing innovative solutions that address the underlying causes of prevalent ophthalmic diseases, such as glaucoma and dry eye. The company's portfolio includes both surgical and non-surgical solutions designed to improve patient outcomes by targeting the root causes of these conditions, rather than simply managing symptoms. With a strong emphasis on clinical evidence and physician education, Sight Sciences is establishing a leading position in the ophthalmology market by offering differentiated technologies that improve the standard of care and expand the treatment paradigm for these debilitating eye diseases.
sight sciences's headcount breakdown by department
| Department | HeadCount |
|---|---|
Administrative | 2 |
Consulting | 4 |
Service | 4 |
Design | 0 |
Education | 0 |
The departmental breakdown at Sight Sciences strongly suggests a commercially-oriented organization deeply invested in driving market adoption of its ophthalmic technologies. The substantial sales team (76 employees) underscores the crucial role of direct sales and marketing efforts in the medical device industry, where building relationships with ophthalmologists and demonstrating the clinical benefits of their products are paramount. Complementing this is a significant medical affairs team (24 employees), indicating a commitment to robust clinical validation, physician training, and ongoing scientific communication, all vital for securing physician buy-in and favorable reimbursement pathways. The technical (16) and research (6) teams, while smaller, likely focus on refining existing technologies and developing incremental innovations driven by market feedback and clinical insights. A lean operations (2) presence may imply reliance on outsourced manufacturing, allowing Sight Sciences to focus on commercialization and strategic growth. The moderate size of the finance (15), HR (7), and 'other' (29) departments demonstrates the requisite back-office functions required to support a company of this scale. The department distribution indicates a well-defined business model focused on accelerating the commercialization of clinically proven ophthalmic technologies and maximizing market penetration within the ophthalmology sector.
sight sciences's employees by locations
Employee Count by Country
Total: 208 employees
Sight Sciences exhibits a geographically focused operational footprint, with a clear emphasis on the United States, where the majority of its workforce (191 employees) is based. This concentration underscores the strategic importance of the US market, the largest and most lucrative market for medical devices globally. The presence of smaller teams in the United Kingdom (9 employees) and Germany (6 employees) signifies an early-stage effort to establish a foothold in key European markets, reflecting the need for local expertise to navigate regulatory landscapes and market access challenges. The minimal representation in Italy (1 employee) and India (1 employee) suggests preliminary market exploration or potentially remote support roles. The geographic strategy aligns with the company's growth stage, prioritizing market penetration in the US while cautiously expanding into select European countries. As Sight Sciences continues to scale, a more diversified global presence, particularly in other European countries and potentially in emerging markets, could be expected to further drive growth and market share in the ophthalmology space.
Want to stay ahead of sight sciences's org changes?
Get alerts when hiring spikes or teams shift focus
Track changes vs. competitors
Spot warm GTM signals early